Quick Takeaways
- Walleye Capital LLC filed SCHEDULE 13G/A for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY).
- Disclosed ownership: 4.8%.
- Date of event: 31 Dec 2024.
Walleye Capital LLC - 31 Dec 2024 SCHEDULE 13G/A Report for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY)
- Filing Manager
- Walleye Capital LLC
- Reporting Manager
- Walleye Capital LLC
- Symbol
- UNCY
- Shares outstanding
- 103,734,440 shares
- Disclosed Ownership
- 5,000,000 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Feb 2025, 15:08:55 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Walleye Capital LLC disclosed 4.8% ownership in UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Feb 2025, 15:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Walleye Capital LLC | 4.8% | 5,000,000 | 5,000,000 | 0 | Thomas Wynn | Thomas Wynn, Global Chief Compliance Officer |